Clinical trial 1407 GUCC TIGER
A Randomized phase III trial comparing conventional-dose chemotherapy using paclitaxel, ifosfamide, and cisplatin (TIP) with high dose chemotherapy using mobilizing paclitaxel plus ifosfamide followed by high-dose carboplatin and etoposide (TI-CE) as first salvage treatment in relapsed or refractory germ cell tumors
| Cancers | |
|---|---|
| Organ | Testicles |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | EORTC |
| EudraCT Identifier | 2014-003930-17 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02375204 |
| Inclusion criteria | Germ cell tumor |
| Last update |